Pathological characteristics, PCNA labeling index and DNA index in prognostic evaluation of patients with moderately differentiated hepatocellular carcinoma

被引:19
作者
Zeng, WJ
Liu, GY
Xu, J
Zhou, XD
Zhang, YE
Zhang, N
机构
[1] Fudan Univ, Sch Med, Dept Pathol, Shanghai 200032, Peoples R China
[2] Fudan Univ, Liver Canc Res Inst, Shanghai 200032, Peoples R China
关键词
D O I
10.3748/wjg.v8.i6.1040
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To study the relationship between prognosis and pathological characteristics, proliferating cell nuclear antigen labeling index (PCNA-LI) and DNA index (DI) in patients with moderately differentiated hepatocellular carcinoma(HCC). METHODS: 51 cases of moderately differentiated HCC were analyzed with respect to the relation between their clinical follow-up data and pathological characteristics. Meanwhile, PCNA-LI of HCC cells was detected by immunohistochemistry assay and DI was measured by Feulgen staining and automatic image analysis technique. RESULTS: Patients with a single tumor nodule, less than 5 cm in diameter, no tumor emboli, no daughter nodules and necrosis had relatively better prognosis; patients with euploidy HCC had better prognosis than those with aneuploidy; among the aneuploidy patients those with DI <1.5 had better prognosis than the cases with DI>1.5; The higher the PCNA-LI, the worse would be the prognosis. The increase in DI was correlated with the increase in PCNA-LI, and both of them were correlated with the pathological changes of the tumor. CONCLUSION: A composite analysis of the pathological characteristics of tumor tissue, DI and PCNA-LI might be useful in predicting the prognosis of HCC patients.
引用
收藏
页码:1040 / 1044
页数:5
相关论文
共 31 条
[1]   The fucosylation index of serum α-fetoprotein as useful prognostic factor in patients with hepatocellular carcinoma in special reference to chronological changes [J].
Aoyagi, Y ;
Mita, Y ;
Suda, T ;
Kawai, K ;
Kuroiwa, T ;
Igarashi, M ;
Kobayashi, M ;
Waguri, N ;
Asakura, H .
HEPATOLOGY RESEARCH, 2002, 23 (04) :287-295
[2]   Tissue inhibitors of metalloproteinases: evolution, structure and function [J].
Brew, K ;
Dinakarpandian, D ;
Nagase, H .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 2000, 1477 (1-2) :267-283
[3]   CYCLIN (PCNA, AUXILIARY PROTEIN OF DNA POLYMERASE-DELTA) IS A CENTRAL COMPONENT OF THE PATHWAY(S) LEADING TO DNA-REPLICATION AND CELL-DIVISION [J].
CELIS, JE ;
MADSEN, P ;
CELIS, A ;
NIELSEN, HV ;
GESSER, B .
FEBS LETTERS, 1987, 220 (01) :1-7
[4]  
Closset J, 1999, HEPATO-GASTROENTEROL, V46, P2914
[5]   The prognostic value of metalloproteinases and angiogenic factors in ovarian carcinoma [J].
Davidson, B ;
Goldberg, I ;
Gotlieb, WH ;
Kopolovic, J ;
Ben-Baruch, G ;
Nesland, JM ;
Reich, R .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2002, 187 (1-2) :39-45
[6]   Differences in survival based on the type of follow-up for the detection of hepatocellular carcinoma: an analysis of 547 patients [J].
Dohmen, K ;
Shirahama, M ;
Onohara, S ;
Miyamoto, Y ;
Torii, Y ;
Irie, K ;
Ishibashi, H .
HEPATOLOGY RESEARCH, 2000, 18 (02) :110-121
[7]   High rates of hepatocellular carcinoma in cirrhotic patients with high liver cell proliferative activity [J].
Donato, MF ;
Arosio, E ;
Del Ninno, E ;
Ronchi, G ;
Lampertico, P ;
Morabito, A ;
Balestrieri, MR ;
Colombo, M .
HEPATOLOGY, 2001, 34 (03) :523-528
[8]  
Fan J, 2001, WORLD J GASTROENTERO, V7, P28
[9]   Occurrence of portal vein tumor thrombus in hepatocellular carcinoma affects prognosis and survival. A retrospective clinical study of 150 cases [J].
Giannelli, G ;
Pierri, F ;
Trerotoli, P ;
Marinosci, F ;
Serio, G ;
Schiraldi, O ;
Antonaci, S .
HEPATOLOGY RESEARCH, 2002, 24 (01) :50-59
[10]  
Gschwendtner A, 1999, J PATHOL, V189, P576, DOI 10.1002/(SICI)1096-9896(199912)189:4<576::AID-PATH455>3.0.CO